Cellectis S.A.
CLLS
$3.24
-$0.08-2.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -68.74% | -45.78% | -18.24% | 117.11% | 107.48% |
| Total Other Revenue | 14.10% | 28.89% | -26.09% | 7.68% | 1.73% |
| Total Revenue | -62.05% | -37.25% | -19.51% | 105.89% | 91.42% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -62.05% | -37.25% | -19.51% | 105.89% | 91.42% |
| SG&A Expenses | 13.02% | 18.89% | -2.64% | 0.79% | 30.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 23.28% | 85.21% | 580.85% | 12.00% | 44.90% |
| Total Operating Expenses | 9.52% | 24.83% | 14.37% | 1.05% | 3.99% |
| Operating Income | -145.34% | -77.49% | -62.46% | 174.65% | 44.29% |
| Income Before Tax | 8.18% | 2.26% | -515.49% | 102.55% | 6.78% |
| Income Tax Expenses | -- | -- | -182.30% | -- | -- |
| Earnings from Continuing Operations | 8.08% | 2.00% | -544.41% | 102.55% | 6.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.08% | 2.00% | -544.41% | 102.55% | 6.07% |
| EBIT | -145.34% | -77.49% | -62.46% | 174.65% | 44.29% |
| EBITDA | -215.59% | -98.84% | -105.70% | 239.56% | 55.35% |
| EPS Basic | 8.37% | 2.38% | -543.07% | 102.56% | 15.50% |
| Normalized Basic EPS | 8.52% | 2.56% | -228.65% | 102.56% | 16.11% |
| EPS Diluted | 8.37% | 2.38% | -562.61% | 102.56% | 15.50% |
| Normalized Diluted EPS | 8.52% | 2.56% | -228.65% | 102.49% | 16.11% |
| Average Basic Shares Outstanding | 0.34% | 0.37% | 0.23% | 0.23% | 11.14% |
| Average Diluted Shares Outstanding | 0.34% | 0.37% | 0.23% | 1.61% | 11.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |